Mechanisms of Transcription Regulation by c-Myc
Mechanisms of Transcription Regulation by c-Myc
批准号:
6922094
负责人:
ERNEST MARTINEZ
金额:
$24.19万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-15 至 2009-04-30
关键词:
HeLa cellsRNA interferenceacetylationacyltransferasecell proliferationchromatinenzyme activityenzyme complexgene expressiongene induction /repressiongenetic promoter elementgenetic regulationgenetic transcriptionlysineneoplastic celloncoproteinspolymerase chain reactionprotein bindingprotein protein interactionprotein structure functiontissue /cell culturetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
c-Myc (Myc) is a DNA-binding transcription factor that heterodimerizes with an obligatory partner, Max, to regulate transcription of genes important for cell proliferation, differentiation, and apoptosis. Myc is highly regulated and is required for normal embryonic development. Deregulated Myc expression is associated with disorders characterized by excess cell proliferation, including cancer and cardiovascular disease. All known functions of Myc require its N-terminal transcription regulatory domain (TAD). However, the cofactors and molecular mechanisms that mediate Myc TAD functions have remained elusive. Thus, elucidating the mechanisms by which Myc regulates transcription is of general medical relevance. Recent observations, including our own, suggest possible roles of histone acetyltransferases (HATs) in regulating Myc functions. We have purified a multisubunit transcription coactivator complex, STAGA, which contains the human HAT GCN5, TRRAP, and other transcription cofactors. STAGA associates with Myc in vivo and in vitro via direct physical interactions with the TAD domain. We postulate that Myc recruits HAT complexes, including STAGA, to its regulatory DNA sequences on target genes and that this allows transcription activation through mechanisms that we propose to investigate. In Specific Aim 1 we will analyze the role of chromatin acetylation, STAGA, and specific STAGA/GCN5-interacting coactivators in transcription regulation by Myc. We will use both cell-free (in vitro) and tissue culture (in vivo) transcription assays, including modified chromatin immunoprecipitation (CHIP) protocols to analyze the function of the Myc-coactivator/HAT associations. In Specific Aim 2 we will address the possible regulation of Myc:Max functions by p300 and the role(s) of Myc:Max acetylation. In Specific Aim 3 we will characterize the Myc-STAGA/p300 protein interface. We will map the region(s) of Myc TAD that directly interact with STAGA and p300 by using GST pull-down and co-immunoprecipitation assays. We will identify the STAGA subunit(s) that contacts Myc TAD in crosslinking experiments. This proposal constitutes the first phase of our long-term goal to understand the role of coactivators and acetylation in regulation of transcription and cell proliferation by Myc.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
-
批准号:10762157
-
项目类别:
-
资助金额:$138.05万
-
财政年份:2023
-
负责人:ERNEST MARTINEZ
-
依托单位:
Capacity Development Core
-
批准号:10762289
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2023
-
负责人:ERNEST MARTINEZ
-
依托单位:
Project 1
-
批准号:10762160
-
项目类别:
-
资助金额:$14.61万
-
财政年份:2023
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
-
批准号:10762287
-
项目类别:
-
资助金额:$135.85万
-
财政年份:2023
-
负责人:ERNEST MARTINEZ
-
依托单位:
MARC at University of California Riverside
-
批准号:10629831
-
项目类别:
-
资助金额:$52.14万
-
财政年份:2023
-
负责人:ERNEST MARTINEZ
-
依托单位:
Administrative Core
-
批准号:10762288
-
项目类别:
-
资助金额:$23.53万
-
财政年份:2023
-
负责人:ERNEST MARTINEZ
-
依托单位:
Full Project 1
-
批准号:10762290
-
项目类别:
-
资助金额:$22.07万
-
财政年份:2023
-
负责人:ERNEST MARTINEZ
-
依托单位:
Role of MYC Acetylation in Oncogenic Transformation
-
批准号:10159869
-
项目类别:
-
资助金额:$3.51万
-
财政年份:2020
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (ADMIN-CORE)
-
批准号:10006593
-
项目类别:
-
资助金额:$4.7万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (ADMIN-CORE)
-
批准号:10469598
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
-
批准号:10006525
-
项目类别:
-
资助金额:$24.19万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (Pilot Project 1)
-
批准号:10006592
-
项目类别:
-
资助金额:$11.14万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
-
批准号:10246842
-
项目类别:
-
资助金额:$24.19万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
Role of MYC Acetylation in Cancer
-
批准号:10020361
-
项目类别:
-
资助金额:$7.02万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
-
批准号:10478277
-
项目类别:
-
资助金额:$21.16万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
-
批准号:10469596
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
-
批准号:10249136
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (ADMIN-CORE)
-
批准号:10249140
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
-
批准号:10006559
-
项目类别:
-
资助金额:$30.53万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (Pilot Project 1)
-
批准号:10249139
-
项目类别:
-
资助金额:$10.2万
-
财政年份:2019
-
负责人:ERNEST MARTINEZ
-
依托单位:
海外基金